Impairment of health-related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium.
Jennifer J G WelchYael FlamandKristen E StevensonDonna S NeubergUma H AthaleKara M KellyCaroline LaverdiereBruno MichonAndrew E PlaceStephen E SallanLewis B SilvermanLynda M VroomanPublished in: Pediatric blood & cancer (2023)
This report examines HR-QoL for children with ALL during treatment longitudinally by parent and patient report across multiple domains. Children with ALL demonstrated substantial impairment in HR-QoL, particularly related to fatigue during intensive consolidation therapy including asparaginase.